Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Hemalatha G Rangarajan, MD, Marcelo De Souza Pereira, Ruta Brazauskas, PhD, Michael R Verneris, MD, Andrew St. Martin, MS, Stephen R. Spellman, MS, Dean Anthony Lee, MD PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-139891

Published: 2020

Journal Articles

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Elizabeth Stenger, MD, Rachel Phelan, MDMPH, Bronwen E. Shaw, MD PhD, Minoo Battiwalla, MD, Stephanie Bo-Subait, MPH, Ruta Brazauskas, PhD, David K. Buchbinder, MD MSHS, Betty K. Hamilton, MD, Shalini Shenoy, MD, Lakshmanan Krishnamurti, MD

Blood (2019) 134 (Supplement_1): 697.

https://doi.org/10.1182/blood-2019-128797

Published: 2019

Journal Articles

Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Neel S. Bhatt, Ruta Brazauskas, PhD, Stephanie Bo-Subait, MPH, Rachel B. Salit, MD, Karen Syrjala, PhD, Heather R. Tecca, Minoo Battiwalla, MD, David K. Buchbinder, MD MSHS, Betty K. Hamilton, MD, Rachel Phelan, MDMPH, Bronwen E. Shaw, MD PhD

Blood (2019) 134 (Supplement_1): 706.

https://doi.org/10.1182/blood-2019-124151

Published: 2019

Journal Articles

Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transplantation for Acute Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Catherine J. Lee, MD, Soyoung Kim, Heather R. Tecca, Ruta Brazauskas, PhD, Minoo Battiwalla, MD, David K. Buchbinder, MD MSHS, Mary E. D. Flowers, MD, Rachel Phelan, MDMPH, Bronwen E. Shaw, MD PhD, Lori S Muffly, MD

Blood (2018) 132 (Supplement 1): 252.

https://doi.org/10.1182/blood-2018-99-113031

Published: 2018

Journal Articles

Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation

Megan Herr, PhD, Rochelle E. Curtis, Margaret A. Tucker, Heather R. Tecca, Eric A. Engels, MD MPH, Elizabeth Cahoon, Minoo Battiwalla, MD, David K. Buchbinder, MD MSHS, Mary E. D. Flowers, MD, Ruta Brazauskas, PhD, Bronwen E. Shaw, MD PhD, Lindsay M. Morton, PhD

Blood (2018) 132 (Supplement 1): 249.

https://doi.org/10.1182/blood-2018-99-116261

Published: 2018

Journal Articles

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Jason Tay, MD, Ruta Brazauskas, PhD, Naya He, Sara Beattie, Christopher Bredeson, MD FRCPC, MSc, Jignesh Dalal, MD, Shahrukh K. Hashmi, MD MPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2018-99-117027

Published: 2018

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Kira O Bona, MDMPH, Ruta Brazauskas, PhD, Naya He, Leslie E. Lehmann, MD, Joanne Wolfe, MD MPH, Jignesh Dalal, MD, Shahrukh K. Hashmi, MDMPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Christine Duncan, MD MSc, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 714.

https://doi.org/10.1182/blood-2018-99-118544

Published: 2018

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Mary Eapen, MBBS, MS, Ruta Brazauskas, PhD, Michael T. Hemmer, MS, Waleska S Pérez, MPH, Patricia Steinart, PhD, Mary M. Horowitz, MD MS, H. Joachim Deeg, MD

Blood (2017) 130 (Supplement 1): 598.

https://doi.org/10.1182/blood.V130.Suppl_1.598.598

Published: 2017

Journal Articles

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Anita D'Souza, MBBS, Heather R. Millard, MPH, Jennifer Knight, MD, Ruta Brazauskas, PhD, Jenny Vogel, Deborah Mattila, Kathryn Flynn, PhD, Stephanie J Lee, MD MPH, Mary M. Horowitz, MD MS, J. Douglas Rizzo, MD, Bronwen E. Shaw, PhD MRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3447.

https://doi.org/10.1182/blood.V130.Suppl_1.3447.3447

Published: 2017

Journal Articles

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Maxim Norkin, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, Ruta Brazauskas, PhD, Heather R. Millard, MPH, Mary E. Flowers, MD, Minoo Battiwalla, MD, Bipin N. Savani, MD, Marcie L. Riches, MDMS, Juan Gea-Banacloche, MD, John R. Wingard, MD

Blood (2017) 130 (Supplement 1): 334.

https://doi.org/10.1182/blood.V130.Suppl_1.334.334

Published: 2017

Journal Articles

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 335.

https://doi.org/10.1182/blood.V130.Suppl_1.335.335

Published: 2017

Journal Articles

Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia

Staci D Arnold, MD MBA, Ruta Brazauskas, PhD, Naya He, MPH, Yimei Li, PhD, Prakash Satwani, MD MBBS, Michael A Pulsipher, MD, Matt Hall, PhD, Yoshiko Atsuta, MD PhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, Carmem Bonfim, MD, Nandita Khera, MD, Richard Aplenc, MD PhD, Wael Saber, MD MS

Blood (2016) 128 (22): 3575.

https://doi.org/10.1182/blood.V128.22.3575.3575

Published: 2016

Journal Articles

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

Kristjan Paulson, MD, Ruta Brazauskas, PhD, Naya He, MPH, David Szwajcer, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Yoshiko Atsuta, MD PhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, Carmem Bonfim, MD, Nandita Khera, MD, Linda J. Burns, MD, Lih-Wen Mau, PhD MPH, Navneet S. Majhail, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 842.

https://doi.org/10.1182/blood.V128.22.842.842

Published: 2016

Journal Articles

A Study of Predictors of Clinical Outcomes and Healthcare Utilization in Children with Sickle Cell Disease Undergoing Allogeneic Hematopoietic Cell Transplantation

Prakash Satwani, MD MBBS, Ruta Brazauskas, PhD, Staci D. Arnold, MD MBA, Naya He, PhD, Yimei Li, PhD, Richard Aplenc, MD PhD, Matt Hall, PhD, Yoshiko Atsuta, MDPhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, ZheZhen Jin, PhD, Carmem Sales-Bonfim, MD PhD, Nandita Khera, MD, Wael Saber, MD MS

Blood (2015) 126 (23): 528.

https://doi.org/10.1182/blood.V126.23.528.528

Published: 2015

Journal Articles

The Impact of Pre-Transplant Depression on Outcomes of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, MD, Yi-Bin Chen, MD, Ruta Brazauskas, PhD, Naya He, PhD, Stephanie J. Lee, MD MPH, Jennifer M Knight, MD, Theresa Hahn, PhD, Nandita Khera, MD, Jignesh D Dalal, MD, Carmem Bonfim, MD, Yoshiko Atsuta, MDPhD, Wael Saber, MD MS

Blood (2015) 126 (23): 265.

https://doi.org/10.1182/blood.V126.23.265.265

Published: 2015

Journal Articles

Comparison of Post-Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes after Matched Related Donor Versus Matched Unrelated Donor HCT in Adults with Acute Lymphoblastic Leukemia

Eric Segal, BS, Michael Martens, MS, Hai-Lin Wang, MPH, Ruta Brazauskas, PhD, Daniel Weisdorf, MD, Brenda M. Sandmaier, MD, Marcos J de Lima, MD, H. Jean Khoury, MD, Wael Saber, MD MS

Blood (2015) 126 (23): 2017.

https://doi.org/10.1182/blood.V126.23.2017.2017

Published: 2015

Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Blood (2014) 124 (21): 209.

https://doi.org/10.1182/blood.V124.21.209.209

Published: 2014

Journal Articles

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

William A. Wood, MD, MPH, Stephanie J. Lee, MD, MPH, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Mahmoud D. Aljurf, MD, Karen K. Ballen, MD, David K. Buchbinder, MD, MSHS, Jason Dehn, MPH, CHTC, César O Freytes, MD, Hillard M. Lazarus, MD, Charles F. LeMaistre, MD, Paulette Mehta, MD, MPH, David Szwajcer, MD, FRCPC, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 554.

https://doi.org/10.1182/blood.V122.21.554.554

Published: 2013

Journal Articles

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Xianxin Li, MD, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Amal Al-Seraihy, K. Scott Baker, MD, MS, Jean-Yves Cahn, MD, Haydar A. Frangoul, MD, James L. Gajewski, MD, Gregory A. Hale, MD, Jack W. Hsu, MD, Rammurti T. Kamble, MD, Hillard M. Lazarus, MD, Richard T. Maziarz, MD, Bipin N. Savani, MD, Ami J. Shah, MD, Mohamed L. Sorror, MD, MSc, William A. Wood, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 917.

https://doi.org/10.1182/blood.V122.21.917.917

Published: 2013

NARROW

Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transplantation for Acute Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

A Study of Predictors of Clinical Outcomes and Healthcare Utilization in Children with Sickle Cell Disease Undergoing Allogeneic Hematopoietic Cell Transplantation

The Impact of Pre-Transplant Depression on Outcomes of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

Comparison of Post-Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes after Matched Related Donor Versus Matched Unrelated Donor HCT in Adults with Acute Lymphoblastic Leukemia

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only